Skip to main content

Advertisement

SpringerLink
Log in

Soluble interleukin-2 receptor and interleukin-6 levels: Evaluation during cyclosporin a and methotrexate treatment in psoriatic arthritis

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Spadaro A, Taccari E, Riccieri V, Sensi F, Sili Scavalli A, Zoppini A. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with main clinical and laboratory parameters. Clin Exp Rheumatol 1996;14:413–6.

    PubMed  Google Scholar 

  2. Salvarani C, Macchioni P, Boiardi L, Rossi F, Maldini MC, Beltrandi E, et al. Low dose cyclosporin A in psoriatic arthitis: relation between soluble interleukin 2 receptors and response to therapy. J Rheumatol 1992;19:74–9.

    PubMed  Google Scholar 

  3. Holt I, Cooper G, Denton J, Meager A, Hopkins SJ. Cytokine interrelationships and their association with disease activity in arthritis. Br J Rheumatol 1992;31:725–33.

    PubMed  Google Scholar 

  4. Holt I, Cooper RG, Hopkins J. Relationship between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Invest 1991;21:479–84.

    PubMed  Google Scholar 

  5. Spadaro A, Riccieri V, Sili Scavalli A, Sensi F, Taccari E, Zoppini A. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: one year prospective study. Clin Exp Rheumatol 1995;13:489–493.

    PubMed  Google Scholar 

  6. Barrera B, Boerboons AMT, Janssen EM, Sauerwein RW, Gallati H, Mulder J, et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Arthritis Rheum 1993;36:1070–9.

    PubMed  Google Scholar 

  7. Crilly S, Kolta S, Dougados M, Sturrock RD, Amor B, Capell HA, et al. Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor levels in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:137–9.

    PubMed  Google Scholar 

  8. Polisson RP, Dooley MA, Dawson DW, Pisetsky DS. Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1994;37:50–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Rheumatology, University ‘La Sapienza’, Policlinico Umberto I, 00161, Rome, Italy

    A. Spadaro, E. Taccari, F. Sensi, V. Riccieri, A. Sili Scavalli & A. Zoppini

Authors
  1. A. Spadaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Taccari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Sensi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Riccieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Sili Scavalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Zoppini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spadaro, A., Taccari, E., Sensi, F. et al. Soluble interleukin-2 receptor and interleukin-6 levels: Evaluation during cyclosporin a and methotrexate treatment in psoriatic arthritis. Clin Rheumatol 17, 83–85 (1998). https://doi.org/10.1007/BF01450970

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01450970

Keywords

Search

Navigation